Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis

Integrating the transcriptome and proteome reveals two prognostic biomarkers for breast cancer, particularly for the estrogen receptor positive subset.

Proteomics and its applications in breast cancer.

Identification of Prognostic Biomarkers for Glioblastoma Based on Transcriptome and Proteome Association Analysis - Jiabin Wang, Shi Yan, Xiaoli Chen, Aowen Wang, Zhibin Han, Binchao Liu, Hong Shen, 2022

Full article: Cytochrome b561 Serves as a Potential Prognostic Biomarker and Target for Breast Cancer

Integrating SWATH-MS Proteomics and Transcriptome Analysis Identifies CHI3L1 as a Plasma Biomarker for Early Gastric Cancer: Molecular Therapy - Oncolytics

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy - ScienceDirect

Identification of potential diagnostic and prognostic biomarkers for breast cancer based on gene expression omnibus

Integrative analysis of the proteome and transcriptome in gastric cancer identified LRP1B as a potential biomarker

Frontiers Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery

Cancers, Free Full-Text

Proteogenomic Analysis of Breast Cancer Transcriptomic and Proteomic Data, Using De Novo Transcript Assembly: Genome-Wide Identification of Novel Peptides and Clinical Implications - ScienceDirect